Skip to main content

Table 1 Basic characteristics

From: RETRACTED ARTICLE: Efficacy of dexmedetomidine as an adjunct to ropivacaine in bilateral dual-transversus abdominis plane blocks in patients with ovarian cancer who underwent cytoreductive surgery

 

CON (n = 29)

TAP-R (n = 29)

TAP-DR (n = 30)

P-value

Age (years), mean (range)

57 (32–73)

56 (38–70)

58 (46–72)

.598

Height (cm), mean (SD)

160 (4)

160 (4)

158 (4)

.469

Weight (kg), mean (SD)

60 (7)

60 (6)

59 (6)

.313

BMI (kg/m2), mean (SD)

23.5 (2.6)

23.3 (2.0)

23.2 (2.0)

.891

ASA physical status, n (%)

.856

 I

5 (17)

7 (24)

4 (13)

 

 II

8 (28)

8 (28)

10 (33)

 

 III

16 (55)

14 (49)

16 (53)

 

Surgical time (min), mean (SD)

250 (55)

243 (52)

244 (58)

.864

Anesthesia time (min), mean (SD)

281 (58)

277 (51)

280 (59)

.965

PACU time (min), mean (SD)

63 (13)

67 (16)

65 (13)

.450

Blood loss (mL), median (IQR)

700 (400–1000)

550 (375–800)

450 (275–637)

.103

Intravenous fluid volume (ml), median (IQR)

3200 (2575–3550)

3100 (2575–3850)

2700 (2175–3200)

.063

Urine volume (mL), median (IQR)

450 (300–600)

500 (388–600)

500 (400–600)

.565

  1. Abbreviations: ASA American Society of Anesthesiologists, SD standard deviation, IQR interquartile range, RMB Renminbi, PACU post-anesthesia case unit, TAP-R Bd-TAP block with 0.3% ropivacaine, TAP-DR Bd-TAP block with 0.3% ropivacaine and 0.5 μg/kg of dexmedetomidine, CON Bd-TAP block with 0.9% normal saline